Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  New England Journal of Medicine

• Publication date

  1993-06-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199306173282402PMID 8497283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic sequencing.

  1993cited by this paper
• Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension.

  1992cited by this paper
• Regulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development.

  1992cited by this paper
• Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines.

  1992cited by this paper
• Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

  1991cited by this paper
• Elevated plasma levels of endothelin-1 in systemic sclerosis.

  1991cited by this paper
• Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung.

  1991cited by this paper
• The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes.

  1991cited by this paper
• Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action.

  1991cited by this paper
• Increased resistance in postobstructive pulmonary vasculopathy: structure-function relationships.

  1991cited by this paper
• Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

  1991cited by this paper
• Production of endothelin by vascular smooth muscle cells.

  1991cited by this paper
• Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells.

  1990cited by this paper
• Inducibleendothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells

  1990cited by this paper
• Endothelins, peptides with potent vasoactive properties, are produced by human macrophages

  1990cited by this paper
• Endothelin is a potent mitogen for rat vascular smooth muscle cells.

  1989cited by this paper
• Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells.

  1989cited by this paper
• A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts.

  1989cited by this paper
• Endothelium‐derived relaxing and contracting factors

  1989cited by this paper
• Presence of endothelin-1 in porcine spinal cord: isolation and sequence determination.

  1989cited by this paper
• Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells.

  1989cited by this paper
• Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells

  1988cited by this paper
• Localization of collagen mRNA in normal and scleroderma skin by in‐situ hybridization

  1988cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Endothelium-derived relaxing factor.

  1988cited by this paper
• Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

  1988cited by this paper
• PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY

  1987cited by this paper
• In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes

  1986cited by this paper
• Genomic sequencing.

  1984cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Grading of pulmonary vascular lesions‐a reappraisal

  1981cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

  1978cited by this paper
• PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTOR*

  1958cited by this paper
• The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects

  1958cited by this paper

• Pharmacokinetics, Safety Profile, and Tolerability of MN-08 Tablets after Single and Multiple Ascending Doses in Healthy Chinese Volunteers.

  2026cites this paper
• Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension

  2026cites this paper
• cAMP-enriched extracellular vesicles improve outcomes in pulmonary hypertension.

  2026cites this paper
• Advances in and Clinical Experience with Subcutaneous Infusion Pump Therapy for Pulmonary Arterial Hypertension.

  2026cites this paper
• Updates on Pulmonary Hypertension

  2025cites this paper
• Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited - A Multigenerational Perspective.

  2025cites this paper
• Unveiling the Dual Benefits of Bosentan in Systemic Sclerosis: Risk and Relief

  2025cites this paper
• Endothelin-1 Overexpression in Pulmonary Endarterectomy Specimens of CTEPH patients is associated with Pulmonary Hypertension Development.

  2025cites this paper
• Prognostic Value of Plasma Big Endothelin-1 in Patients Hospitalized for Heart Failure

  2025cites this paper
• Reduction in Circulating Endothelin-1 Levels by Inhaled COPD Medications.

  2025cites this paper
• Resolution of inflammation in pulmonary arterial hypertension, the influence of sex—An IUPHAR immunopharmacology committee review

  2025cites this paper
• Integrated Stress Response (ISR) Modulators in Vascular Diseases

  2025cites this paper
• Identification of Common Angiogenesis Marker Genes in Chronic Lung Diseases and Their Relationship with Immune Infiltration Based on Bioinformatics Approaches

  2025cites this paper
• History of Respiratory Medicine in Canada: Pulmonary hypertension

  2025cites this paper
• Endocrinology and the Lung: Exploring the Bidirectional Axis and Future Directions

  2025cites this paper
• Endothelial dysfunction in middle-aged and older men with low testosterone is associated with elevated circulating endothelin-1

  2025cites this paper
• DIAGNÓSTICO

  2025cites this paper
• Signaling pathways and targeted therapy for pulmonary hypertension

  2025cites this paper
• BMP9-mediated regulation of endothelin-1 requires integrated SMAD1/5 and SMAD2/3 signaling

  2025cites this paper
• Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review

  2025cites this paper
• The Relevance of Endothelial Dysfunction Biomarkers in Thalassemia Patients and Healthy Individuals: A Systematic Review and Meta-Analysis

  2025cites this paper
• The Efficacy of Pharmacological Interventions in Pulmonary Arterial Hypertension (WHO Group 1): A Systematic Review of Randomized Controlled Trials

  2025cites this paper
• Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy

  2024cites this paper
• Transpulmonary Plasma Endothelin-1 Arterial:Venous Ratio Differentiates Survivors from Non-Survivors in Critically Ill Patients with COVID-19-Induced Acute Respiratory Distress Syndrome

  2024cites this paper
• Hypertension artérielle pulmonaire idiopathique et états apparentés

  2024cites this paper
• Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain

  2024cites this paper
• Pulmonary hypertension in patients affected by sleep-related breathing disorders: up to date from the literature.

  2024cites this paper
• Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review

  2024cites this paper
• Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension

  2024cites this paper
• Kidney transplantation in the presence of pulmonary hypertension: A clinical dilemma

  2024cites this paper
• The Impact of Pulmonary Disorders on Neurological Health (Lung-Brain Axis)

  2024cites this paper
• GCN2 kinase activation mediates pulmonary vascular remodeling and pulmonary arterial hypertension

  2024cites this paper
• Vessels and pressures: Update on the management of pulmonary arterial hypertension

  2024cites this paper
• Human Pulmonary Artery Endothelial Cells Increased Glycolysis and Decreased Nitric Oxide Synthase O-GlcNAcylation in Pulmonary Arterial Hypertension

  2024cites this paper
• Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

  2024cites this paper
• Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes

  2024cites this paper
• Pulmonary hypertension associated to left heart disease: Phenotypes and treatment.

  2024cites this paper
• The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan

  2024cites this paper
• Pulmonary hypertension impairs vasomotor function in rat diaphragm arterioles.

  2024cites this paper
• Bosentan in the treatment of persistent pulmonary hypertension in newborns: a systematic review and meta-analysis.

  2024cites this paper
• Investigation of pulmonary artery and circulating endothelin-1 expression in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease

  2024cites this paper
• Recent developments in connective tissue disease associated pulmonary arterial hypertension

  2024cites this paper
• Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats

  2024cites this paper
• Novel insights into the potential applications of stem cells in pulmonary hypertension therapy

  2024cites this paper
• Indigo Leaves-Induced Pulmonary Arterial Remodeling without Right Ventricular Hypertrophy in Rats.

  2024cites this paper
• The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges

  2023cites this paper
• Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

  2023cites this paper
• Endothelial IK and SK channel activation decreases pulmonary arterial pressure and vascular remodeling in pulmonary hypertension

  2023cites this paper
• The Unexpected Role of GCN2 Kinase Activation in Mediating Pulmonary Arterial Hypertension

  2023cites this paper
• Effect of Phosphodiesterase-5 (PDE-5) Inhibitors on Clinical Outcomes in Patients With Pulmonary Hypertension: A Meta-Analysis of Randomized Control Trials

  2023cites this paper
• Therapeutic benefits of nitric oxide in lung transplantation.

  2023cites this paper
• Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives

  2023cites this paper
• Contribution of Mitochondrial Reactive Oxygen Species to Chronic Hypoxia-Induced Pulmonary Hypertension

  2023cites this paper
• Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.

  2023cites this paper
• Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide.

  2023cites this paper
• A Bioinformatic Algorithm based on Pulmonary Endoarterial Biopsy for Targeted Pulmonary Arterial Hypertension Therapy

  2023cites this paper
• Regulation of Pulmonary Hypertension

  2023cites this paper
• Management of Pulmonary Arterial Hypertension

  2023cites this paper
• Pulmonary Circulation Under Pressure: Pathophysiological and Therapeutic Implications of BK Channel

  2023cites this paper
• Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD

  2023cites this paper
• Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation.

  2023cites this paper
• Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease

  2023cites this paper
• Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management

  2023cites this paper
• A Lifelike guided journey through the pathophysiology of pulmonary hypertension—from measured metabolites to the mechanism of action of drugs

  2023cites this paper
• Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?

  2023cites this paper
• Advances in the discovery of drugs that treat pulmonary arterial hypertension

  2023cites this paper
• Oh NO! Loss of PHD2 leads to “radical” changes in the lung vasculature

  2022cites this paper
• Pathogenic Mechanisms of Pulmonary Arterial Hypertension

  2022influential citation
• Vascular pathobiology of pulmonary hypertension.

  2022cites this paper
• Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice

  2022cites this paper
• Pathophysiology and Pathogenic Mechanisms of Pulmonary Hypertension: Role of Membrane Receptors, Ion Channels and Ca2+ Signaling.

  2022cites this paper
• Inhibition of JAK1,2 Prevents Fibrotic Remodeling of Pulmonary Vascular Bed and Improves Outcomes in the Rat Model of Chronic Thromboembolic Pulmonary Hypertension

  2022cites this paper
• TASK-1 Channels: Functional Role in Arterial Smooth Muscle Cells

  2022cites this paper
• Pathophysiology of Chronic Bronchial Infection in Bronchiectasis.

  2022cites this paper
• Endothelin-1 Alters BMP Signaling to Promote Proliferation of Pulmonary Artery Smooth Muscle Cells.

  2022cites this paper
• Iron deficiency and pulmonary arterial hypertension.

  2022cites this paper
• NiONP-Induced Oxidative Stress and Mitochondrial Impairment in an In Vitro Pulmonary Vascular Cell Model Mimicking Endothelial Dysfunction

  2022cites this paper
• Biomarker prognostication across Universal Definition of Heart Failure stages

  2022cites this paper
• The Seventeenth International Conference on Endothelin (ET-17).

  2022cites this paper
• The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.

  2022cites this paper
• Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease

  2022cites this paper
• Circulating Blood-Based Biomarkers in Pulmonary Hypertension

  2022cites this paper
• Global longitudinal strain assessment of cardiac function and extravascular lung water formation after diving using semi-closed circuit rebreather

  2022cites this paper
• Adjunct ambrisentan therapy had clinical benefits in 5 dogs with sildenafil-refractory pulmonary hypertension.

  2022cites this paper
• Connexins may play a critical role in cigarette smoke-induced pulmonary hypertension

  2022cites this paper
• The Glycobiology of Pulmonary Arterial Hypertension

  2022cites this paper
• Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

  2022cites this paper
• Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going

  2022cites this paper
• Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension

  2022cites this paper
• Increased plasma glutamate in non-smokers with vasospastic angina pectoris is associated with plasma cystine and antioxidant capacity

  2022cites this paper
• Anti-arthritic and toxicological evaluation of ethanolic extract of Alternanthera bettzickiana in rats

  2022cites this paper
• Update on Medical Management of Pulmonary Arterial Hypertension.

  2022cites this paper
• Immunohistochemical profile of the pulmonary vasculature in subjects with cirrhosis and histopathologic evidence of pulmonary vascular disease: An autopsy study.

  2022cites this paper
• Role of solid lipid nanoparticle for the delivery of Lipophilic Drugs and Herbal Medicines in the treatment of pulmonary hypertension.

  2022cites this paper
• “The possible implication of endothelin in the pathology of COVID-19-induced pulmonary hypertension”

  2021cites this paper
• Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019

  2021cites this paper
• Effect of Pravastatin as an Adjunctive Therapeutic for Mitral Insufficiency with Hyperlipidemia in a Dog

  2021cites this paper
• Notch2 Suppression Mimicking Changes in Human Pulmonary Hypertension Modulates Notch1 and Promotes Endothelial Cell Proliferation.

  2021cites this paper
• Novel Pharmacological Targets for Pulmonary Arterial Hypertension.

  2021cites this paper
• Increased intracellular Cl- Concentrations in Pulmonary Arterial Myocytes Associated with Chronic Hypoxic Pulmonary Hypertension.

  2021cites this paper